Ghost Tree Capital, LLC Historic Quarter Change: USA Options, Added

Ghost Tree Capital, LLC historic quarter change: USA Options, Added

In put and call options, at their filed underlying value (listed in the US), over 14 quarters from 2013-12-31 to 2024-09-30, Ghost Tree Capital, LLC opened 86 positions, added to 10, reduced 5 and sold out of 79.

Q3 2016: Stock XBI; Country of operation —; Class S&P BIOTECH · Put; Shares before 400,000.
Q3 2016: Stock SRPT; Country of operation United States; Class COM · Call; Shares before 100,000.
Q3 2016: Stock SRPT; Country of operation United States; Class COM · Put; Shares before 300,000.
Q3 2016: Stock BSX; Country of operation United States; Class COM · Call; Shares before 350,000.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1595851), 14 quarters: Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-17); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-09-09); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-18); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2013-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

Quarter	Stock	Country of operation	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q3 2016	XBI SPDR SERIES TRUST		S&P BIOTECH · Put	400,000	750,000	+350,000	$21,632,000	$49,718,000	+$28,086,000	2016-11-14
Q3 2016	SRPT SAREPTA THERAPEUTICS INC	United States	COM · Call	100,000	350,000	+250,000	$1,907,000	$21,494,000	+$19,587,000	2016-11-14
Q3 2016	SRPT SAREPTA THERAPEUTICS INC	United States	COM · Put	300,000	400,000	+100,000	$5,721,000	$24,564,000	+$18,843,000	2016-11-14
Q3 2016	BSX BOSTON SCIENTIFIC CORP	United States	COM · Call	350,000	450,000	+100,000	$8,180,000	$10,710,000	+$2,530,000	2016-11-14
Q3 2016	HORIZON PHARMA PLC CUSIP G4617B105		SHS · Call	200,000	300,000	+100,000	$3,294,000	$5,439,000	+$2,145,000	2016-11-14
Q2 2016	IWM ISHARES TR		RUSSELL 2000 ETF · Put	75,000	350,000	+275,000	$8,297,000	$40,243,000	+$31,946,000	2016-08-12
Q2 2016	XBI SPDR SERIES TRUST		S&P BIOTECH · Put	220,000	400,000	+180,000	$11,037,000	$21,632,000	+$10,595,000	2016-08-12
Q2 2015	AVALANCHE BIOTECHNOLOGIES IN CUSIP 05337G107		COM · Call	100,000	150,000	+50,000	$4,052,000	$2,436,000	-$1,616,000	2015-09-09
Q2 2014	MYLAN INC CUSIP 628530907		CALL · Call	100,000	150,000	+50,000	$4,883,000	$7,734,000	+$2,851,000	2014-08-14
Q1 2014	TEVA PHARMACEUTICAL INDS LTD CUSIP 881624909		CALL · Call	100,000	150,000	+50,000	$4,008,000	$7,926,000	+$3,918,000	2014-05-15

Similar Firms

Firm Name	Country	13F Value	Holdings
Not available yet